Skip to content

Qianqian Wu

3 papers in the library · publishing 2026

Papers

Sort Most recent Most cited

Esketamine’s therapeutic effect on anhedonia in adolescents: a post-hoc of a randomized controlled trial

BMC Psychiatry October 7, 2026 Qianqian Wu, Weicheng Li, Zhanjie Luo et al.

Abstract Background Anhedonia, a prominent symptom of major depressive disorder (MDD), severely impairs patients’ quality of life and is challenging to treat. Although esketamine has shown potential in treating anhedonia in adult treatment-resistant MDD, its effects on adolescents remain under-explored. Methods In this study, a prospective, randomized, double-blind, controlled trial was...

Esketamine's Therapeutic Effect on Anhedonia: A Post-hoc of a Randomized Controlled Trial

Research Square July 20, 2026 Qianqian Wu, Weicheng Li, Zhanjie Luo et al. preprint

Abstract Background: Anhedonia, a prominent symptom of major depressive disorder (MDD), severely impairs patients' quality of life and is challenging to treat. Although esketamine has shown potential in treating anhedonia in adult treatment-resistant MDD, its effects on adolescents remain under-explored. Methods: In this study, a prospective, randomized, double-blind, controlled trial was...

Effects of sub-anesthetic doses of esketamine on immune function and postoperative negative emotions in acoustic neuroma patients: a randomized clinical trial.

Annals of medicine July 3, 2026 Zheping Chen, Yaozhu Wang, Peilin Cong et al.

Patients undergoing acoustic neuroma (AN) surgery often experience postoperative negative emotions, including anxiety, depression, and immune function suppression. This trial evaluated whether perioperative sub-anesthetic esketamine improves early postoperative negative emotions and immune function. In this single-center, double-blind, randomized trial, 84 patients scheduled for AN surgery were...